Cubist Systematic Strategies’s VistaGen Therapeutics VTGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,088
| Closed | -$25.2K | – | 2385 |
|
|
2025
Q1 | $25.2K | Buy |
+10,088
| New | +$25.2K | ﹤0.01% | 1335 |
|
|
2023
Q3 | – | Sell |
-41,363
| Closed | -$77.3K | – | 2622 |
|
|
2023
Q2 | $77.3K | Buy |
+41,363
| New | +$77.3K | ﹤0.01% | 1858 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3608 |
|
|
2022
Q3 | – | Sell |
-950
| Closed | -$25K | – | 3918 |
|
|
2022
Q2 | $25K | Buy |
950
+180
| +23% | +$4.74K | ﹤0.01% | 3649 |
|
|
2022
Q1 | $29K | Buy |
+770
| New | +$29K | ﹤0.01% | 3422 |
|
|
2021
Q4 | – | Sell |
-493
| Closed | -$41K | – | 3655 |
|
|
2021
Q3 | $41K | Sell |
493
-2,862
| -85% | -$238K | ﹤0.01% | 2853 |
|
|
2021
Q2 | $317K | Buy |
3,355
+79
| +2% | +$7.46K | ﹤0.01% | 2293 |
|
|
2021
Q1 | $209K | Buy |
3,276
+2,620
| +399% | +$167K | ﹤0.01% | 2446 |
|
|
2020
Q4 | $38K | Buy |
+656
| New | +$38K | ﹤0.01% | 2484 |
|